Newron Pharma Raises €30 Million
ItalianCNS drug-discovery firm Newron Pharmaceuticals said last week that it has raised €30 million ($39.8 million) in venture capital funding.
HBM Partners, on behalf of HBM BioCapital and HBM Bioventures, led the financing round. Existing investors 3i Group, Apax Partners, and Atlas Ventures all participated in the round, as well.
Newron said that approximately €23 million in funding closed last week, while the remaining €7 million would remain open for a few weeks.